Diagnosed mental illness, physical health condition more prevalent in seniors who self-harm
TUESDAY, Oct. 16, 2018 (HealthDay News) — Most older adults who self-harm are not referred to mental health services, according to a study published online Oct. 15 in The Lancet Psychiatry.
Catharine Morgan, Ph.D., from Manchester University in the United Kingdom, and colleagues identified 4,124 adults aged 65 years and older with a self-harm episode ascertained from Read codes recorded during 2001 to 2014. The standardized incidence was calculated, and the frequency of psychiatric referrals and prescription of psychotropic medication after self-harm was examined in 2,854 adults with at least 12 months of follow-up.
The researchers found that during the 13-year period, the overall incidence of self-harm was 4.1 per 10,000 person-years, with stable gender-specific rates. Overall, 11.7 percent of the 2,854 adults were referred to mental health services after self-harm; 59.3 and 11.8 percent were prescribed an antidepressant and a tricyclic antidepressant, respectively. Relative to the comparison cohort, the prevalence of having previously diagnosed mental illness and prevalence of having a previous physical health condition was higher in the self-harm cohort (prevalence ratios, 2.10 and 1.20, respectively). During the first year, adults from the self-harm cohort died from unnatural causes an estimated 20 times more often than those in the comparison cohort. The self-harm cohort had a markedly increased risk for suicide (hazard ratio, 145.4).
“Health care professionals should take the opportunity to consider the risk of self-harm when an older person consults with other health problems,” the authors write.
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions